Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Scleroderma, Limited”

25 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 25 results

Large-scale testing (Phase 3)Active Not RecruitingNCT05925803
What this trial is testing

Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)

Who this might be right for
Systemic SclerosisScleroderma
AstraZeneca 314
Not applicableStudy completedNCT06772896
What this trial is testing

Evaluating the Effect of Questionnaire Context on the Reporting of Somatic Items Among People With Systemic Sclerosis

Who this might be right for
SclerodermaSystemic Sclerosis (SSc)Scleroderma (Limited and Diffuse)
Lady Davis Institute 851
Not applicableEnded earlyNCT02298777
What this trial is testing

Metabolomic Analysis of Systemic Sclerosis

Who this might be right for
Scleroderma (Limited and Diffuse)Undifferentiated Connective Tissue DiseaseRaynaud Disease+2 more
University Hospital, Strasbourg, France 121
Large-scale testing (Phase 3)Ended earlyNCT01016067
What this trial is testing

Tibial Delayed Healing Pivotal Clinical Trial

Who this might be right for
Tibial Delayed Healing
Medtronic Spinal and Biologics 23
Large-scale testing (Phase 3)Study completedNCT01347008
What this trial is testing

Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis

Who this might be right for
Scleroderma, SystemicScleroderma, DiffuseScleroderma, Limited+1 more
Federal University of São Paulo 41
Not applicableWithdrawnNCT02531009
What this trial is testing

Systemic Sclerosis Clinical and Biomarker Study

Who this might be right for
HealthySystemic Sclerosis
Biogen
Not applicableStudy completedNCT00812188
What this trial is testing

Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.

Who this might be right for
Symmetric Limited Morphea
University of Texas Southwestern Medical Center 24
Testing effectiveness (Phase 2)UnknownNCT04927390
What this trial is testing

Mycophenolate in Limited Cutaneous Systemic Sclerosis (MINIMISE-Pilot)

Who this might be right for
Systemic SclerosisLimited Cutaneous Systemic Sclerosis
University College, London 120
Not applicableActive Not RecruitingNCT07661836
What this trial is testing

Personalized Online Occupational Therapy Intervention for Adults With Scleroderma

Who this might be right for
SclerodermaScleroderma (Limited and Diffuse)Systemic Sclerosis (SSc)
Universidad de Zaragoza 24
Testing effectiveness (Phase 2)Study completedNCT00775463
What this trial is testing

Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine

Who this might be right for
Systemic SclerosisScleroderma
United Therapeutics 148
Not applicableLooking for participantsNCT07182981
What this trial is testing

Patients Diagnosed With Scleroderma and Their Chewing and Swallowing Performance

Who this might be right for
Systemic Sclerosis (SSc)SclerodermaScleroderma (Limited and Diffuse)+2 more
Hacettepe University 50
Not applicableLooking for participantsNCT07292961
What this trial is testing

Investigating the Effectiveness of the Biopsychosocial Model-Based Exercise Approach in Children and Adults Diagnosed With Scleroderma

Who this might be right for
SclerodermaScleroderma, LocalizedScleroderma Systemic+4 more
Hacettepe University 48
Not applicableLooking for participantsNCT07183072
What this trial is testing

Patients Diagnosed With Scleroderma: Physical Performance and Functionality

Who this might be right for
Systemic Sclerosis (SSc)SclerodermaScleroderma (Limited and Diffuse)+2 more
Hacettepe University 50
Not applicableLooking for participantsNCT07182968
What this trial is testing

Cultural Adaptation, Validity, and Reliability of the Turkish Version of The PASTUL Questionnaire

Who this might be right for
Systemic Sclerosis (SSc)Systemic Sclerosis (Scleroderma)Scleroderma (Limited and Diffuse)+1 more
Hacettepe University 50
Not applicableNot Yet RecruitingNCT07015060
What this trial is testing

Pathogenic Mechanisms Involved in the Initiation and Progression of Systemic Sclerosis

Who this might be right for
Scleroderma (Limited and Diffuse)
Université Catholique de Louvain 15
Large-scale testing (Phase 3)Ended earlyNCT02374320
What this trial is testing

Exparel as a Nerve Block for Severe Hand Pain

Who this might be right for
CREST SyndromePeripheral Vascular DiseaseRaynaud Disease+1 more
Jose Soberon, MD 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT02682511
What this trial is testing

Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension

Who this might be right for
Scleroderma, DiffuseScleroderma, SystemicScleroderma, Limited+5 more
Cumberland Pharmaceuticals 34
Not applicableStudy completedNCT06425653
What this trial is testing

Exercise With Scleroderma Functional Outcomes

Who this might be right for
Scleroderma, SystemicScleroderma, DiffuseScleroderma, Limited+2 more
Trakya University 44
Large-scale testing (Phase 3)Study completedNCT00740285
What this trial is testing

Effectiveness and Safety of Lidocaine for Scleroderma

Who this might be right for
Scleroderma
Federal University of São Paulo 26
Not applicableStudy completedNCT01072669
What this trial is testing

Efficacy of Ambrisentan in Limited Scleroderma Patients in Improving Blood Flow to Hands or Feet

Who this might be right for
Ischemia
Soumya Chatterjee 20
Next Page